Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – N-c doai
Patent
1991-11-27
1993-07-20
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
N-c doai
5483381, 560160, 564153, 514616, C07D23364, A61K 3116, C07C27116, C07C23322
Patent
active
052294200
ABSTRACT:
Non-peptidyl compounds characterized generally as ethereal N-terminal aminodiol derivatives of amino acids are useful as renin inhibitors for the treatment of hypertension. Compounds of particular interest are of the formula ##STR1## wherein X is selected from oxygen atom and methylene; wherein R.sub.1 is selected from methyl, ethyl, t-butyloxycarbonyl and 2-(N-piperidinyl)ethyl; wherein R.sub.2 is selected from hydrido, methyl, ethyl and isopropyl; wherein R.sub.3 is selected from benzyl, phenethyl, pyridylmethyl and 2-pyridylethyl; wherein each of R.sub.4 and R.sub.6 is independently selected from hydrido and methyl; wherein R.sub.7 is cyclohexylmethyl; wherein R.sub.8 is isobutyl; wherein each of R.sub.9 and R.sub.11 is hydrido; wherein m is zero or one and n is a number selected from zero through five; or a pharmaceutically-acceptable salt thereof; with the proviso that where m is zero, then R.sub.5 is selected from imidazolemethyl, thiazolemethyl and isobutyl; and with the further proviso that when m is one, then R.sub.5 is methyl or ethyl.
REFERENCES:
patent: 4900745 (1990-02-01), Hanson et al.
patent: 4900746 (1990-02-01), Hanson et al.
patent: 4902706 (1990-02-01), Hanson et al.
Plattner et al., J. Med. Chem. 1988, 31, pp, 2277-2288.
Umezawa et al, in J. Antibiot. (Tokyo), 23:259-262 (1970).
Gross et al, Science, 175, 656 (1971).
Boger, et al, Nature, 303, 81 (1983).
Kokubu et al, Biochim. Biophys. Res. Commun., 118, 929 (1984).
Castro et al, FEBS Lett., 167, 273 (1984).
Hanson et al, Biochm. Biophys. Res. Comm., 132:155-161 (1985), 146:959-963 (1987).
Marshall, Federation Proc., 35: 2494-2501 (1976).
Burton et al, Proc. Natl. Acad. Sci. USA, 77: 5476-5479 (1980).
Suketa et al, Biochemistry, 14: 3188 (1975).
Swales, Pharmac. Ther., 7: 173-201 (1979).
Kokubu et al, Nature, 217: 456-457 (1968).
Matsushita et al, J. Antibiotics, 28: 1016-1018 (1975).
Lazar et al, Biochem. Pharma., 23: 2776-2778 (1974).
Miller et al, Biochem. Pharma., 21: 2941-2944 (1972).
Haber, Clinical Science, 59: 7s-19s (1980).
Rich et al, J. Org. Chem., 43: 3624 (1978).
Rich et al, J. Med. Chem., 23: 27 (1980).
Haber, Clin. and Exper. Hyper., A5(7&8), 1193 (1983).
Baran John S.
Hanson Gunnar J.
G. D. Searle & Co.
Gabilan Mary Susan H.
Keane J. Timothy
Lee Mary C.
Matukaitis Paul D.
LandOfFree
Ethereal N-terminal aminodiol amino acid derivatives as anti-hyp does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ethereal N-terminal aminodiol amino acid derivatives as anti-hyp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ethereal N-terminal aminodiol amino acid derivatives as anti-hyp will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1760995